Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Blood (2023) 142 (Supplement 1): 1762.

https://doi.org/10.1182/blood-2023-174647

Published: 2023

Journal Articles

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Blood (2022) 140 (Supplement 1): 6690–6692.

https://doi.org/10.1182/blood-2022-157438

Published: 2022

Journal Articles

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2021) 138 (Supplement 1): 2451.

https://doi.org/10.1182/blood-2021-146340

Published: 2021

Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Blood (2019) 134 (Supplement_1): 350.

https://doi.org/10.1182/blood-2019-126798

Published: 2019

Journal Articles

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Blood (2016) 128 (22): 3029.

https://doi.org/10.1182/blood.V128.22.3029.3029

Published: 2016

Journal Articles

Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era

Nozomi Niitsu, MDPhD, Naoki Takahashi, Tadashi Yoshino, MD PhD, Masataka Okamoto, MD PhD, Shigeo Nakamura, MD PhD

Blood (2015) 126 (23): 3911.

https://doi.org/10.1182/blood.V126.23.3911.3911

Published: 2015

Journal Articles

HHV8-Negative Body Cavity-Based Lymphoma Is Mature Large B-Cell Lymphoma That Affects Elderly and Displays Favorable Prognosis: A Multi-Center Retrospective Study of 50 Patients in Japan

Daisuke Kaji, Yasunori Ota, Yasuharu Sato, Koji Nagafuji, Masataka Okamoto, Yasushi Terasaki, Naoko Tsuyama, Tomohiro Kinoshita, Shuichi Taniguchi, Koichi Ohshima, Koji Izutsu

Blood (2014) 124 (21): 2969.

https://doi.org/10.1182/blood.V124.21.2969.2969

Published: 2014

Journal Articles

Clinicopathological Features and Prognosis of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma with t(14;18) and 8q24 Translocation in the Rituximab Era

Nozomi Niitsu, MD, PhD, Naoki Takahashi, Mika Kohri, Norio Asou, MD PhD, Jun-ichi Tamaru, Jun Sakai, Shigeo Nakamura, Ikuo Miura, Masataka Okamoto

Blood (2014) 124 (21): 1633.

https://doi.org/10.1182/blood.V124.21.1633.1633

Published: 2014

Journal Articles

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

Dai Chihara, MD PhD, Naoko Asano, MD PhD, Ohmachi Ken, Momoko Nishikori, MD, PhD, Masataka Okamoto, Masashi Sawa, Rika Sakai, MD PhD, Yasushi Okoshi, MD PhD, Norifumi Tsukamoto, MD PhD, Yoshihiro Yakushijin, MDPhD, Shigeo Nakamura, MD PhD, Tomohiro Kinoshita, Michinori Ogura, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2014) 124 (21): 1660.

https://doi.org/10.1182/blood.V124.21.1660.1660

Published: 2014

Journal Articles

A Varicella Outbreak in Diffuse Large B-Cell Lymphoma Patients Receiving Rituximab-Containing Chemotherapy

Akinao Okamoto, MD, Akihiro Abe, MD PhD, Masataka Okamoto, Yoko Inaguma, MD, Tokuda Masutaka, MDPhD, Satoko Morishima, MD, PhD, Masamitsu Yanada, Tadaharu Kanie, MDPhD, Yukiya Yamamoto, MD PhD, Shuichi Mizuta, MD PhD, Yoshiki Akatsuka, MD PhD, Tetsushi Yoshikawa, MDPhD, Nobuhiko Emi, MDPhD

Blood (2014) 124 (21): 5439.

https://doi.org/10.1182/blood.V124.21.5439.5439

Published: 2014

Journal Articles

Simplified MIPI Is a Valid Prognostic Index In The Rituximab Era: Multicenter MCL Study In Japan

Dai Chihara, MD, PhD, Naoko Asano, MD, Ph.D., Tomohiro Kinoshita, MD, PhD, Yoshinobu Maeda, MD, PhD, Kosei Matsue, MD, PhD, Ken Ohmachi, M.D., Masataka Okamoto, MD, PhD, Ishikazu Mizuno, MD, Toshiki Uchida, MD, PhD, Hirokazu Nagai, MD, PhD, Michinori Ogura, M.D., Ph.D., Ritsuro Suzuki, MD

Blood (2013) 122 (21): 4257.

https://doi.org/10.1182/blood.V122.21.4257.4257

Published: 2013

Journal Articles

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Shigeru Kusumoto, MD, PhD, Yasuhito Tanaka, MD, PhD, Ritsuro Suzuki, M.D., Takashi Watanabe, MD, PhD, Masanobu Nakata, MD, Hirotaka Takasaki, MD, Noriyasu Fukushima, MD, PhD, Takuya Fukushima, MD, PhD, Yukiyoshi Moriuchi, MD, Kuniaki Itoh, MD, PhD, Kisato Nosaka, MD, PhD, Ilseung Choi, MD, Masashi Sawa, MD, PhD, Rumiko Okamoto, MD, Hideki Tsujimura, MD, PhD, Toshiki Uchida, MD, PhD, Sachiko Suzuki, MD, PhD, Masataka Okamoto, MD, PhD, Tsutomu Takahashi, MD, PhD, Isamu Sugiura, MD, PhD, Yasushi Onishi, MD, PhD, Mika Kohri, MD, PhD, Shinichiro Yoshida, MD, PhD, Rika Sakai, MD, Minoru Kojima, MD, PhD, Hiroyuki Takahashi, MD, PhD, Akihiro Tomita, MD, PhD, Dai Maruyama, MD, PhD, Yoshiko Atsuta, MD, PhD, Eiji Tanaka, MD, PhD, Takayo Suzuki, MD, PhD, Tomohiro Kinoshita, M.D., Ph.D., Michinori Ogura, MD, PhD, Masashi Mizokami, MD, PhD, Ryuzo Ueda, MD, PhD

Blood (2012) 120 (21): 2641.

https://doi.org/10.1182/blood.V120.21.2641.2641

Published: 2012

Journal Articles

Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

Ritsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, Go Yamamoto, Kenzo Takada, Yasuaki Harabuchi, Yasushi Isobe, Hiroshi Gomyo, Tadashi Koike, Masataka Okamoto, Rie Hyo, Junji Suzumiya, Shigeo Nakamura, Keisei Kawa, Kazuo Oshimi, the NK-cell Tumor Study Group

Blood (2011) 118 (23): 6018–6022.

https://doi.org/10.1182/blood-2011-05-354142

Published: 2011

Includes: Supplemental data

Journal Articles

A Study on nm23-H1 Expression in Hodgkin Lymphoma That Was Treated with BEACOPP Therapy

Nozomi Niitsu, Kumiko Yoshitake, Hirokazu Nakamine, Masataka Okamoto

Blood (2011) 118 (21): 4861.

https://doi.org/10.1182/blood.V118.21.4861.4861

Published: 2011

Journal Articles

Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

Blood (2010) 116 (24): 5119–5125.

https://doi.org/10.1182/blood-2010-06-289231

Published: 2010

Includes: Supplemental data

Journal Articles

Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era.

Miyuki Hayama, Masataka Okamoto, MD, PhD, Yuki Hagiwara, Ken Tanae, Mika Kohri, Naoki Takahashi, Tadashi Yoshino, Koichi Ohshima, Nozomi Niitsu, MD

Blood (2010) 116 (21): 1800.

https://doi.org/10.1182/blood.V116.21.1800.1800

Published: 2010

Journal Articles

Multicenter Phase II Study of the CyclOBEAP Regimen for Patients with Peripheral T-Cell Lymphoma with Analysis of Biomakers.

Nozomi Niitsu, MD, PhD, Miyuki Hayama, MD, PhD, Yuki Hagiwara, Ken Tanae, Mika Kohri, Naoki Takahashi, Shigeo Nakamura, MD, Jun-ichi Tamaru, Masataka Okamoto, MD, PhD

Blood (2010) 116 (21): 2795.

https://doi.org/10.1182/blood.V116.21.2795.2795

Published: 2010

Journal Articles

Multicenter Phase II Study of the CyclOBEAP Plus Rituximab in Diffuse Large B-Cell Lymphoma with Analysis of Biomakers.

Nozomi Niitsu, Mika Kohri, Yuki Hagiwara, Ken Tanae, Handa Kohsuke, Naoki Takahashi, Masami Bessho, Masataka Okamoto

Blood (2009) 114 (22): 2725.

https://doi.org/10.1182/blood.V114.22.2725.2725

Published: 2009

Journal Articles

The Impact of Outcome and Hepatic Toxicity in HCV-Infected Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus CHOP Therapy; A Retrospective Multicenter Japanese Analysis.

Blood (2009) 114 (22): 2700.

https://doi.org/10.1182/blood.V114.22.2700.2700

Published: 2009

Journal Articles

Prospective Measurement of EBV-DNA in Plasma and Peripheral Blood Mononuclear Cells of Extranodal NK/T-Cell Lymphoma, Nasal Type.

Ritsuro Suzuki, MD, PhD, Motoko Yamaguchi, MD, PhD, Koji Izutsu, MD, Go Yamamoto, Kenzo Takada, Yasuaki Harabuchi, Yasushi Isobe, Hiroshi Gomyo, Tadashi Koike, Masataka Okamoto, Junji Suzumiya, MD, Shigeo Nakamura, MD, Keisei Kawa, Kazuo Oshimi, MD

Blood (2009) 114 (22): 135.

https://doi.org/10.1182/blood.V114.22.135.135

Published: 2009

NARROW

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era

HHV8-Negative Body Cavity-Based Lymphoma Is Mature Large B-Cell Lymphoma That Affects Elderly and Displays Favorable Prognosis: A Multi-Center Retrospective Study of 50 Patients in Japan

Clinicopathological Features and Prognosis of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma with t(14;18) and 8q24 Translocation in the Rituximab Era

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

A Varicella Outbreak in Diffuse Large B-Cell Lymphoma Patients Receiving Rituximab-Containing Chemotherapy

Simplified MIPI Is a Valid Prognostic Index In The Rituximab Era: Multicenter MCL Study In Japan

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Prospective measurement of Epstein-Barr virus–DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

A Study on nm23-H1 Expression in Hodgkin Lymphoma That Was Treated with BEACOPP Therapy

Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era.

Multicenter Phase II Study of the CyclOBEAP Regimen for Patients with Peripheral T-Cell Lymphoma with Analysis of Biomakers.

Multicenter Phase II Study of the CyclOBEAP Plus Rituximab in Diffuse Large B-Cell Lymphoma with Analysis of Biomakers.

The Impact of Outcome and Hepatic Toxicity in HCV-Infected Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus CHOP Therapy; A Retrospective Multicenter Japanese Analysis.

Prospective Measurement of EBV-DNA in Plasma and Peripheral Blood Mononuclear Cells of Extranodal NK/T-Cell Lymphoma, Nasal Type.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only